Taysha Gene Therapies, Inc. (TSHA)
NASDAQ: TSHA · Real-Time Price · USD
4.590
+0.020 (0.44%)
At close: Mar 9, 2026, 4:00 PM EDT
4.640
+0.050 (1.09%)
After-hours: Mar 9, 2026, 5:41 PM EDT
Taysha Gene Therapies Market Cap
Taysha Gene Therapies has a market cap or net worth of $1.26 billion as of March 9, 2026. Its market cap has increased by 274.07% in one year.
Market Cap
1.26B
Enterprise Value
1.03B
1-Year Change
274.07%
Ranking
Category
Stock Price
$4.59
Market Cap Chart
Since the IPO on September 24, 2020, Taysha Gene Therapies's market cap has increased from $690.43M to $1.26B, an increase of 82.10%. That is a compound annual growth rate of 11.63%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zenas BioPharma | 1.36B |
| Corvus Pharmaceuticals | 1.32B |
| Immatics | 1.32B |
| EyePoint | 1.31B |
| Savara | 1.30B |
| MoonLake Immunotherapeutics | 1.30B |
| Septerna | 1.29B |
| AtaiBeckley | 1.23B |